This is a video synopsis/summary of an Insights involving Allison Wheeler, MD. Wheeler addresses the nuanced considerations for implementing prophylaxis in patients with mild to moderate hemophilia A, ...
Findings showed concizumab-treated patients had an 86% reduction in annualized bleeding rate compared with no prophylaxis. The Food and Drug Administration (FDA) has approved Alhemo ® (concizumab-mtci ...
The urinary antiseptic methenamine hippurate (Hiprex) was non-inferior to antibiotic prophylaxis in women with a history of recurrent urinary tract infections (UTI), according to results from the ...
Please provide your email address to receive an email when new articles are posted on . Concizumab prophylaxis led to lower annualized bleeding rates than no prophylaxis. Treatment with concizumab ...
Broad-Spectrum Antibiotic Significantly Reduces Surgical Site Infections After the Whipple Procedure
The broad-spectrum antibiotic piperacillin-tazobactam used as perioperative prophylaxis significantly reduced surgical site infection (SSI) in patients undergoing open pancreatoduodenectomy (PD, or ...
Prophylactic treatment with trimethoprim-sulfamethoxazole (TMP-SMX) significantly reduced the risk for serious infections by approximately 50% in patients with antineutrophil cytoplasmic antibody ...
Long-term prophylaxis (LTP) is the cornerstone strategy to achieve disease control and improve patient quality of life(QoL), because many patients can become virtually attack-free with an acceptable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback